Written by:Fact check:

Overview

What Is Esophageal Cancer?

Esophageal cancer begins in the lining or other tissues of the esophagus, the muscular tube that carries food from the throat to the stomach. The two main types are squamous cell carcinoma and adenocarcinoma. Esophageal cancer can affect adults of any sex, but risk varies with age, geography, ethnicity, and other risk factors. It is also called esophagus cancer or, in some regions, oesophageal cancer.

Symptoms

Symptoms of Esophageal Cancer

Early esophageal cancer may cause no noticeable symptoms. As a tumor grows, swallowing problems may appear or gradually worsen, but these symptoms can also result from conditions that are not cancer. Persistent or worsening swallowing problems should be medically evaluated rather than assumed to be cancer.

  • Difficulty swallowing (dysphagia)
  • Painful swallowing (odynophagia)
  • Unexplained weight loss
  • Chest discomfort
  • Upper-abdominal discomfort
  • Persistent indigestion
  • Persistent heartburn
  • Hoarseness
  • Chronic cough
  • Vomiting
  • Black stools from bleeding

WHEN TO ACT

Do not ignore progressive swallowing problems

Symptoms of esophageal cancer can resemble reflux or other digestive conditions. New, persistent, or progressively worsening difficulty swallowing warrants prompt medical assessment, especially when accompanied by weight loss, bleeding, or persistent pain.

Causes

What Causes Esophageal Cancer?

Esophageal cancer develops when cells acquire changes that allow them to grow without normal control. These abnormal cells can invade nearby tissues and sometimes spread to lymph nodes or distant organs. A single cause is usually not identifiable; instead, several inherited, medical, environmental, and lifestyle factors may contribute.

How the main types develop

Squamous cell carcinoma arises from squamous cells lining much of the esophagus and may be linked with long-term irritation and inflammation. Adenocarcinoma usually develops in glandular cells near the lower esophagus; long-standing acid reflux and Barrett’s esophagus are particularly associated with this type. These associations describe risk patterns, not a guarantee that cancer will develop.

Risk Factors

Risk Factors for Esophageal Cancer

  • Older age is associated with a higher likelihood of esophageal cancer.
  • Male sex is associated with higher rates of several esophageal cancer patterns.
  • A family history or inherited cancer syndrome may increase risk.
  • Previous radiation to the chest or upper abdomen may increase risk.
  • Geographic location and ethnic background are linked with different rates and tumor patterns.
  • Tobacco use increases the risk of esophageal cancer.
  • Heavy alcohol use increases risk, particularly when combined with tobacco use.
  • Obesity is associated especially with esophageal adenocarcinoma.
  • Chronic gastroesophageal reflux disease can irritate the lower esophagus.
  • Barrett’s esophagus is associated with an increased risk of esophageal adenocarcinoma.
  • Achalasia, a disorder that affects movement of food through the esophagus, can increase risk.
  • Frequently drinking very hot beverages may contribute to chronic irritation.
  • A diet low in fruits and vegetables may be associated with higher risk.

Side Effects & Complications

Complications and Treatment Side Effects

Potential complications

Esophageal cancer can cause severe swallowing difficulty, malnutrition, dehydration, bleeding, and involvement of the airway or nearby organs. Advanced disease may spread to distant organs and affect eating, breathing, energy, and comfort. Supportive or palliative care can help manage symptoms at any stage and does not mean that cancer treatment has stopped.

  • Fatigue may occur during or after treatment.
  • Nausea can result from chemotherapy, radiation, or other medicines.
  • Appetite changes may make it harder to maintain nutrition.
  • Mouth or throat irritation can affect eating and drinking.
  • Radiation therapy can cause skin reactions in the treated area.
  • Treatment can increase the risk of infection.
  • Neuropathy may cause numbness, tingling, or pain in the hands or feet.
  • Surgery can cause complications such as infection, bleeding, or changes in digestion.

Diagnosis & Staging

Diagnosis and Staging

  • A medical history and physical examination help assess symptoms, health conditions, and risk factors.
  • Upper endoscopy allows a clinician to view the esophagus and collect a biopsy for laboratory examination.
  • Imaging scans can assess the tumor and look for disease outside the esophagus.
  • Endoscopic ultrasound can help estimate tumor depth and examine nearby lymph nodes.
  • Selected laboratory or molecular tests may help assess overall health and identify biomarkers that influence treatment.

What staging means

Staging describes how far esophageal cancer has developed. It considers how deeply the tumor grows into the esophageal wall, whether nearby lymph nodes contain cancer, and whether the disease has spread to distant organs. Stage I generally describes a more limited tumor, Stage II and Stage III describe increasing local or regional involvement, and Stage IV indicates distant spread; stage alone does not determine an individual’s prognosis.

Treatment Options

Esophageal Cancer Treatment Options

SURGERY

Surgery may remove part or most of the esophagus and nearby tissues when the tumor can be safely resected. It may be combined with other treatments before or after the operation.

CHEMOTHERAPY AND CHEMORADIATION

Chemotherapy uses medicines that circulate through the body, while chemoradiation combines chemotherapy with radiation. These approaches may be used before surgery, after surgery, as a main treatment, or to control advanced disease.

RADIATION THERAPY

Radiation uses high-energy beams to treat cancer in a targeted area. It may be combined with chemotherapy, used around surgery, or used to relieve symptoms caused by advanced disease.

TARGETED THERAPY AND IMMUNOTHERAPY

Targeted medicines act on selected features of cancer cells, and immunotherapy helps the immune system recognize or attack cancer. Biomarker testing helps determine whether these treatments may be appropriate.

ENDOSCOPIC TREATMENT

For carefully selected very early tumors, treatment through an endoscope may remove abnormal tissue without major surgery. Suitability depends on tumor depth, location, and other findings.

SUPPORTIVE AND PALLIATIVE CARE

Nutrition support, swallowing treatment, pain relief, stents, and other measures can improve comfort and function. Palliative care can be provided alongside cancer-directed treatment at any stage.

Treatments may be given before surgery, after surgery, as the main treatment, or to control advanced disease such as stage 4 esophageal cancer. The plan depends on stage, tumor type, location, biomarkers, ability to remove the tumor, and overall health. Clinical trials may provide access to newer approaches.

Treatment planning

Care is tailored to the individual

Discuss goals of care, expected benefits, side effects, nutrition, swallowing support, and clinical-trial eligibility with a multidisciplinary cancer team. Ask how each option fits your diagnosis and personal priorities.

Prevention

Preventing Esophageal Cancer

  • Avoiding tobacco can reduce exposure to an important esophageal cancer risk factor.
  • Limiting alcohol can lower alcohol-related risk.
  • Maintaining a healthy weight may reduce the risk associated with obesity.
  • Managing reflux with medical guidance can reduce ongoing irritation and symptoms.
  • Eating a balanced diet that includes fruits and vegetables supports overall health.
  • Avoiding very hot beverages may reduce repeated heat-related irritation.

There is no routine screening test recommended for average-risk adults. People with Barrett’s esophagus or other high-risk conditions may need individualized endoscopic surveillance based on their clinician’s advice.

Outlook and Prognosis

Outlook and Prognosis

The outlook depends mainly on the stage at diagnosis, whether the tumor can be completely treated, the cancer type and biology, response to therapy, overall health, and access to specialized care. Prognosis for esophageal adenocarcinoma and other types can differ, so information about one group should not be treated as a prediction for every person.

Varies

Outcomes differ between localized, regional, and distant disease.

Group estimates

Five-year relative survival statistics describe populations, not individual outcomes.

Individualized

Tumor biology, treatment response, health, and care access affect prognosis.

Survivorship & Follow-up

Survivorship and Follow-up

  • Scheduled visits help review recovery, treatment response, and possible recurrence.
  • Symptom reviews help identify new or persistent concerns.
  • Selected imaging or endoscopy may be recommended based on treatment and risk.
  • Nutrition and swallowing assessments can address weight loss and eating difficulties.
  • Late effects of surgery, chemotherapy, radiation, or other treatment should be managed.
  • Emotional or practical support can help with anxiety, work, finances, and daily activities.

Follow-up schedules vary by stage, treatment, recurrence risk, and symptoms. Report new swallowing problems, unexplained weight loss, bleeding, or persistent pain promptly. Ongoing esophageal cancer treatment or surveillance should be coordinated with the oncology and primary care teams.

Branches

1 topic

Tests & Procedure

1 topic

Symptoms

3 topics